Results 121 to 130 of about 756,756 (215)

Constitutive Expression of the Vi Polysaccharide Capsular Antigen in AttenuatedSalmonella entericaSerovar Typhi Oral Vaccine Strain CVD 909 [PDF]

, 2000
Jin Yuan Wang, Fernando Noriega, James E. Galen, Eileen M. Barry, Myron M. Levine   +4 more
openalex   +1 more source

A Novel Chitin‐Based Purification System Using GAL1 Fusion Tags: Enhancing Recombinant Protein Production While Retaining Biological Activity

Microbial Biotechnology, Volume 18, Issue 5, May 2025.
A chitin‐based affinity chromatography system using GAL1 as a fusion tag efficiently purifies recombinant proteins while retaining their biological activity, offering a cost‐effective alternative to conventional purification methods. ABSTRACT Efficient and economical purification methods are crucial for the commercial production of recombinant proteins
Yao‐Kuang Tseng, Yun‐Heng Lu, Yun Liu, Zhi‐Wei Weng, Yu‐Tzu Lin, Chih‐Hsuan Tsai, Yueh‐Lung Wu, Rong‐Nan Huang   +7 more
wiley   +1 more source

Comparison of an Opsonophagocytic Assay and IgG ELISA to Assess Responses to Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccines in Children and Young Adults with Sickle Cell Disease [PDF]

, 2000
Louis Vernacchio, Sandra Romero‐Steiner, Joseph Martinez, Kristin MacDonald, Suzanne Barnard, Tamar Pilishvili, G M Carlone, D M Ambrosino, Deborah C. Molrine   +8 more
openalex   +1 more source

Safety evaluation of the food enzyme pullulanase from the non‐genetically modified Klebsiella pneumoniae strain AE‐PUL

EFSA Journal, Volume 23, Issue 5, May 2025.
Abstract The food enzyme pullulanase (pullulan 6‐α‐glucanohydrolase, EC 3.2.1.41) is produced by Amano Enzymes Inc. with the non‐genetically modified Klebsiella pneumoniae strain AE‐PUL, a known human pathogen. The food enzyme is free from viable cells of the production organism and its DNA.
EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Monika Sramkova, Henk Van Loveren, Laurence Vernis, Silvia Peluso, Magdalena Andryszkiewicz, Daniele Cavanna, Ana Criado, Cristina Fernàndez‐Fraguas, Yi Liu   +19 more
wiley   +1 more source

Synthesis of a Set of Staphylococcus Aureus Capsular Polysaccharide Type 1 Oligosaccharides Carrying Taurine Esters

Chemistry – A European Journal, Volume 31, Issue 24, April 25, 2025.
Staphylococcus aureus serotype 1 is a highly virulent pathogen and the capsular polysaccharide (CP1) has been shown to play an important role in virulence and be a target for opsonic antibodies. We here describe the synthesis of a set of CP1 oligosaccharides, varying in length and with different taurination patterns. Abstract Staphylococcus aureus is a
Kitt Emilie Østerlid, Renata Cergano, Herman S. Overkleeft, Gijsbert A. van der Marel, Jeroen D. C. Codée   +4 more
wiley   +1 more source

Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults

Infection and Immunity, 1981
Griffiss Jm, B. Brandt, P. Altieri, G. Pier, S. Berman   +4 more
semanticscholar   +1 more source

Meningococcal C Polysaccharide Vaccine Induces Immunologic Hyporesponsiveness in Adults: Additional Data [PDF]

, 2001
James E. Froeschle, Frederick L. Ruben, Patrick H. McVerry   +2 more
openalex   +1 more source

Preparation, Immunogenicity, and Protective Efficacy, in a Murine Model, of a Conjugate Vaccine Composed of the Polysaccharide Moiety of the Lipopolysaccharide of Vibrio cholerae O139 Bound to Tetanus Toxoid [PDF]

, 2001
A Boutonnier, Sylvain Villeneuve, Farida Nato, B Dassy, Jean‐Michel Fournier   +4 more
openalex   +1 more source

Analysis of immunogenicity and purification methods in conjugated polysaccharide vaccines: a new approach in fighting pathogenic bacteria. [PDF]

Front Immunol
Sheikhi A, Shirmohammadpour M, Mahdei Nasirmahalleh N, Mirzaei B.   +3 more
europepmc   +1 more source

Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults. [PDF]

Nat Immunol
Ravichandran S, Erra-Diaz F, Karakaslar OE, Marches R, Kenyon-Pesce L, Rossi R, Chaussabel D, Nehar-Belaid D, LaFon DC, Pascual V, Palucka K, Paust S, Nahm MH, Kuchel GA, Banchereau J, Ucar D.   +15 more
europepmc   +1 more source